Nunn Jason Raleigh

Director at Zenas BioPharma, Inc. · on record since Sep 16, 2024
Director at Addex Therapeutics Ltd. · on record since Mar 18, 2026
Director at Paratek Pharmaceuticals, Inc. · on record since Feb 2, 2009
Director at HYPERION THERAPEUTICS INC · on record since Jul 25, 2012
Director at TREVENA INC · on record since Jan 30, 2014
Director at TriVascular Technologies, Inc. · on record since Apr 15, 2014
Director at Dermira, Inc. · on record since Oct 2, 2014
Director at Regulus Therapeutics Inc. · on record since Jun 11, 2019

Insider trading activity of Nunn Jason Raleigh

Transactions on record: 86; since Jan 19, 2010

Open-market buys: 3; $16.2M

Open-market sells: 0

Companies traded: 8; last filing Sep 4, 2026

Figures computed from official regulatory filings — .

Companies where Nunn Jason Raleigh has traded

Addex Therapeutics Ltd.4 tx · Sep 4, 2026
Zenas BioPharma, Inc.10 tx · $16.2M · Jun 17, 2026
Regulus Therapeutics Inc.18 tx · Jun 27, 2025
TREVENA INC12 tx · Jun 14, 2024
Dermira, Inc.20 tx · $112.5K · Feb 24, 2020
TriVascular Technologies, Inc.1 tx · May 27, 2015
HYPERION THERAPEUTICS INC10 tx · $1.5M · May 11, 2015
11 tx · Oct 30, 2014

Track record of Nunn Jason Raleigh

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Nunn Jason Raleigh

Co-insiders of Nunn Jason Raleigh

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	Other	-219,561	0.00 USD	—	SEC
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	Award	219,561	0.00 USD	—	SEC
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	AwardD (derivative)	50,000	0.00 USD	—	SEC
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	OtherD (derivative)	-50,000	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Jun 17, 2026	AwardD (derivative)	18,500	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Oct 14, 2025	Buy	63,158	19.00 USD	$1.2M	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-62,500	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-60,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-2,325	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,650	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-9,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-15,000	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Jun 12, 2025	AwardD (derivative)	18,500	0.00 USD	—	SEC
Regulus Therapeutics Inc.Listing unverified	Apr 30, 2025	Award	62,500	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Other	669,061	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Buy	441,176	17.00 USD	$7.5M	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	AwardD (derivative)	37,000	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	OtherD (derivative)	-13,071,439	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Other	1,505,388	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	OtherD (derivative)	-5,809,528	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Buy	441,176	17.00 USD	$7.5M	SEC
TREVENA INCListing on record	Jun 14, 2024	AwardD (derivative)	13,700	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	Other	-219,561	0.00 USD	—	SEC
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	Award	219,561	0.00 USD	—	SEC
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	AwardD (derivative)	50,000	0.00 USD	—	SEC
Addex Therapeutics Ltd.Listing on record	Sep 4, 2026	OtherD (derivative)	-50,000	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Jun 17, 2026	AwardD (derivative)	18,500	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Oct 14, 2025	Buy	63,158	19.00 USD	$1.2M	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-62,500	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-60,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-2,325	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,650	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-9,000	—	—	SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-15,000	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Jun 12, 2025	AwardD (derivative)	18,500	0.00 USD	—	SEC
Regulus Therapeutics Inc.Listing unverified	Apr 30, 2025	Award	62,500	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Other	669,061	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Buy	441,176	17.00 USD	$7.5M	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	AwardD (derivative)	37,000	0.00 USD	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	OtherD (derivative)	-13,071,439	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Other	1,505,388	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	OtherD (derivative)	-5,809,528	—	—	SEC
Zenas BioPharma, Inc.Listing unverified	Sep 16, 2024	Buy	441,176	17.00 USD	$7.5M	SEC
TREVENA INCListing on record	Jun 14, 2024	AwardD (derivative)	13,700	0.00 USD	—	SEC